1. Screening Libraries
  2. Histone Modification Research Compound Library

Histone Modification Research Compound Library

Cat. No.: HY-L024
Library Contents: XLSX PDF

A unique collection of 174 bioactive compounds targeting histone modification for high throughput screening (HTS) and high content screening (HCS).

Histone Modification Research Compound Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

sales@MedChemExpress.cn

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 174 bioactive compounds for high throughput screening (HTS) and high content screening (HCS).

•   Targets include Epigenetic Reader Domain, HDAC, Histone Acetyltransferase, Histone Demethylase, Histone Methyltransferase, Sirtuin, etc.

•   A useful tool for the research of the regulation of histone modification and the corresponding diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC50, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 174 histone modification related compounds supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Histone Modification Research Compound Library

Source: MedChem Express

Contents of Histone Modification Research Compound Library

Plate layout: HY-L024-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Mivebresib HLCL-61 (hydrochloride) GSK6853 EPZ015866 BI-7273 BI-9564 MS049 NKL 22 CPI-455 CPI-637 Empty
b Empty ITSA-1 GSK-LSD1 Dihydrochloride AGK2 BVT948 BVT948 AZD5153 (6-Hydroxy-2-naphthoic acid) Cambinol Histone Acetyltransferase Inhibitor II AS8351 UNC3866 Empty
c Empty WT-161 Salermide EED226 666-15 SIRT2 Inhibitor II GSK3326595 dBET1 WM-1119 Vorinostat CUDC-101 Empty
d Empty Panobinostat Belinostat BET bromodomain inhibitor KG-501 EED inhibitor-1 PF-06726304 CAY10602 Tasquinimod Valproic acid Valproic acid (sodium salt) Empty
e Empty BIX-01294 BAY-299 OSS_128167 3-TYP Tucidinostat UNC0224 UNC0321 Abexinostat HDAC8-IN-1 SR-4370 Empty
f Empty PLX51107 CeMMEC1 (+)-JQ1 PA JQ-35, (S)- Entinostat Mocetinostat MM-102 (TFA) IOX1 UNC0379 PFI-3 Empty
g Empty OF-1 A-366 SP2509 ML324 ORY-1001(trans) GSK503 PTACH (+)-JQ-1 (R)-(-)-JQ1 Enantiomer GSK 525762A Empty
h Empty I-BET151 Droxinostat Tubastatin A (Hydrochloride) Tubastatin-A Pracinostat Tenovin-1 GSK126 GSK343 M344 Sirtinol Empty

Plate layout: HY-L024-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CUDC-907 Dacinostat Daminozide Sulforaphane EPZ-6438 UNC0646 C646 RGFP966 JIB-04 MS436 Empty
b Empty GSK1324726A UNC0642 Resminostat (hydrochloride) Givinostat (hydrochloride monohydrate) Trichostatin A MI-2 MI-3 PCI-34051 EPZ004777 UNC0638 Empty
c Empty EX-527 Scriptaid Tenovin-6 Tenovin 6 (Hydrochloride) EI1 EPZ-5676 UNC1999 BRD9539 GSK-J1 GSK-J2 Empty
d Empty GSK-J4 UNC1215 SGC0946 Sodium phenylbutyrate GSK2801 OTX-015 Bromosporine SGC-CBP30 UNC 669 CPI-203 Empty
e Empty Inauhzin MG 149 C-7280948 CPI-169 racemate Citarinostat 4SC-202 4SC-202 (free base) ACY-1215 RG2833 PFI-1 Empty
f Empty RVX-208 AK-7 BRD4770 Remodelin (hydrobromide) MC1568 EPZ011989 OICR-9429 TMP269 TMP195 PFI-2 (hydrochloride) Empty
g Empty GSK2879552 PFI-4 GSK-5959 BRD73954 BG45 AMI-1 I-BRD9 UF010 LMK-235 LLY-507 Empty
h Empty ACY-738 WDR5-0103 Pimelic Diphenylamide 106 BML-210 NI-57 MS023 XY1 SGC707 HPOB 4-(2-(5-(3,5-Dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine hydrochloride Empty

Plate layout: HY-L024-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BCI-121 BI 2536 CI-994 JQ-1 (carboxylic acid) Nicotinamide Sodium Butyrate Bufexamac Amodiaquin (dihydrochloride dihydrate) Tranylcypromine (hemisulfate) Curcumin Empty
b Empty Fisetin Ginkgolide C Santacruzamate A Anacardic Acid Empty Empty Empty Empty Empty Empty Empty
c Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
d Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Histone Modification Research Compound Library
目录号:
HY-L024
需求量:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.